Functional involvement of organic cation transporter1 (OCT1/Oct1) in the hepatic uptake of organic cations in humans and rats

Xenobiotica

Volumn 37, Issue 8, 2007, Pages 818-831

  Umehara, K I ^a   Iwatsubo, T ^a   Noguchi, K ^a   Kamimura, H ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

Hepatic uptake; Human organic cation transporter 1 (hOCT1); Organic cation transporters; Rat organic cation transporter 1 (rOct1); Uptake of cationic compounds

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; CATION; CIMETIDINE; METFORMIN; ORGANIC CATION TRANSPORTER 1; TETRYLAMMONIUM;

ANIMAL CELL; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIVER CELL; NONHUMAN; PROTEIN EXPRESSION; RAT;

ANIMALS; CARBON RADIOISOTOPES; CELL LINE; CIMETIDINE; CRYOPRESERVATION; DNA, COMPLEMENTARY; HEPATOCYTES; HUMANS; METFORMIN; ORGANIC ANION TRANSPORTERS, SODIUM-INDEPENDENT; ORGANIC CATION TRANSPORTER 1; PYRIDINIUM COMPOUNDS; RATS; TETRAETHYLAMMONIUM; TRANSFECTION; TRITIUM;

RATTUS;

EID: 34547946755     PISSN: 00498254     EISSN: 13665928     Source Type: Journal    
DOI: 10.1080/00498250701546012     Document Type: Article

References (20)

1. Gorboulev V, Ulzheimer JC, Akhoundova A, Ulzheimer-Teuber I, Karbach U, Quester S, Baumann C, Lang F, Busch AE, Koepsell H. 1997. Cloning and characterization of two human polyspecific organic cation transporters. DNA and Cell Biology 16:871-881.
2. Grundemann D, Gorboulev V, Gambaryan S, Veyhl M, Koepsell H. 1994. Drug excretion mediated by a new prototype of polyspecific transporter. Nature 372:549-552.
3. Hasegawa M, Kusuhara H, Endou H, Sugiyama Y. 2003. Contribution of organic anion transporters to the renal uptake of anionic compounds and nucleoside derivatives in rat. Journal of Pharmacology and Experimental Therapeutics 305:1087-1097.
4. Kekuda R, Prasad PD, Wu X, Wang H, Fei YJ, Leibach FH, Ganapathy V. 1998. Cloning and functional characterization of a potential-sensitive, polyspecific organic cation transporter (OCT3) most abundantly expressed in placenta. Journal of Biological Chemistry 273:15971-15979.
5. Kimura N, Masuda S, Tanihara Y, Ueo H, Okuda M, Katsura T, Inui K. 2005. Metformin is a superior substrate for renal organic cation transporter OCT2 rather than hepatic OCT1. Drug Metabolism and Pharmacokinetics 20:379-386.
6. Koepsell H, Schmitt BM, Gorboulev V. 2003. Organic cation transporters. Reviews of Physiology, Biochemistry and Pharmacology 150:36-90.
7. Miyauchi S, Sugiyama Y, Sawada Y, Iga T, Hanano M. 1987. Conjugative metabolism of 4-methylumbelliferone in the rat liver: verification of the sequestration process in multiple indicator dilution experiments. Chemical and Pharmaceutical Bulletin 35:4241-4248.
8. Motohashi H, Uwai Y, Hiramoto K, Okuda M, Inui K. 2004. Different transport properties between famotidine and cimetidine by human renal organic ion transporters (SLC22A). European Journal of Pharmacology 503:25-30.
9. Muller M, Jansen PL. 1997. Molecular aspects of hepatobiliary transport. American Journal of Physiology 272:G1285-G1303.
10. Okuda M, Saito H, Urakami Y, Takano M, Inui K. 1996. cDNA cloning and functional expression of a novel rat kidney organic cation transporter, OCT2. Biochemical and Biophysical Research Communications 224:500-507.
11. Shikata E, Yamamoto R, Takane H, Shigemasa C, Ikeda T, Otsubo K, Ieiri I. (2006). Human organic cation transporter (OCT1 and OCT2) gene polymorphisms and therapeutic effects of metformin. Journal of Human Genetics 17: [Epub before print].
12. Shitara Y, Li AP, Kato Y, Lu C, Ito K, Itoh T, Sugiyama Y. 2003. Function of uptake transporters for taurocholate and estradiol 17β-D-glucuronide in cryopreserved human hepatocytes. Drug Metabolism and Pharmacokinetics 18:33-41.
13. Slitt AL, Cherrington NJ, Hartley DP, Leazer TM, Klaassen CD. 2002. Tissue distribution and renal developmental changes in rat organic cation transporter mRNA levels. Drug Metabolism and Pharmacokinetics 30:212-219.
14. 2-blockers on the organic cation transporters-mediated transport between human (OCT) and rat (oct): Insight into the application to the development of drug candidates. Xenobiotica 37:618-634.
15. Wang DS, Jonker JW, Kato Y, Kusuhara H, Schinkel AH, Sugiyama Y. 2002. Involvement of organic cation transporter 1 in hepatic and intestinal distribution of metformin. Journal of Pharmacology and Experimental Therapeutics 302:510-515.
16. Wang DS, Kusuhara H, Kato Y, Jonker JW, Schinkel AH, Sugiyama Y. 2003. Involvement of organic cation transporter 1 in the lactic acidosis caused by metformin. Molecular Pharmacology 63:844-848.
17. Wu X, Huang W, Ganapathy ME, Wang H, Kekuda R, Conway SJ, Leibach FH, Ganapathy V. 2000. Structure, function, and regional distribution of the organic cation transporter OCT3 in the kidney. AJP: Renal Physiology 279:F449-F458.
18. Yamazaki M, Akiyama S, Nishigaki R, Sugiyama Y. 1996a. Uptake is the rate-limiting step in the overall hepatic elimination of pravastatin at steady-state in rats. Pharmaceutical Research 13:1559-1564.
19. Yamazaki M, Suzuki H, Sugiyama Y. 1996b. Recent advances in carrier-mediated hepatic uptake and biliary excretion of xenobiotics. Pharmaceutical Research 13:497-513.
20. Zhang L, Dresser MJ, Gray AT, Yost SC, Terashita S, Giacomini KM. 1997. Cloning and functional expression of a human liver organic cation transporter. Molecular Pharmacology 51:913-921.